Projects per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology, ASSISTANT PROFESSOR | Cell, Developmental and Regenerative Biology, ASSISTANT PROFESSOR | Oncological Sciences
Biography
Research Topics Anti-Tumor Therapy, Apoptosis/Cell Death, Cancer Genetics, Cell Biology, Cell Cycle, DNA Repair, Drug Design and Discovery, Drug Resistance, Oncogenes, Signal Transduction, Tumor Suppressor Genes Multi-Disciplinary Training Areas Cancer Biology [CAB], Developmental and Stem Cell Biology [DSCB], Genetics and Genomic Sciences [GGS] Education BS/MS, Paris VII University Instructor, Harvard Medical School MS, Paris VI University PhD, Max-Planck Institute for Developmental Biology, University of Tubingen, and Paris VI University Postdoctoral fellowship, Dana-Farber Cancer Institute, Harvard Medical School Language English Awards 2012 Young Scientist Cancer Research Award 2011 Searle Scholar 2009 Claudia Adams Barr Award in Cancer Research 2004 French Foundation for Medical Research (FRM) Scholarship 2003 French Association for Cancer Research (ARC) Scholarship
Fingerprint
Dive into the research topics where Samuel Sidi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
A Non-Canonical IRAK1 Signaling Pathway Triggered by Ionizing Radiation
National Institute of General Medical Sciences
15/09/19 → 30/06/23
Project: Research
-
Mechanisms of PIDDosome Signaling, a p53-Independent Apoptotic Response to DNA Damage
5/07/13 → 31/05/23
Project: Research
-
-
FANCI functions as a repair/apoptosis switch in response to DNA crosslinks
Shah, R. B., Kernan, J. L., van Hoogstraten, A., Ando, K., Li, Y., Belcher, A. L., Mininger, I., Bussenault, A. M., Raman, R., Ramanagoudr-Bhojappa, R., Huang, T. T., D'Andrea, A. D., Chandrasekharappa, S. C., Aggarwal, A. K., Thompson, R. & Sidi, S., 9 Aug 2021, In: Developmental Cell. 56, 15, p. 2207-2222.e7Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Dubiella, C., Pinch, B. J., Koikawa, K., Zaidman, D., Poon, E., Manz, T. D., Nabet, B., He, S., Resnick, E., Rogel, A., Langer, E. M., Daniel, C. J., Seo, H. S., Chen, Y., Adelmant, G., Sharifzadeh, S., Ficarro, S. B., Jamin, Y., Martins da Costa, B., Zimmerman, M. W., & 24 others, Sep 2021, In: Nature Chemical Biology. 17, 9, p. 954-963 10 p.Research output: Contribution to journal › Article › peer-review
29 Scopus citations -
An IRAK1–PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy
Liu, P. H., Shah, R. B., Li, Y., Arora, A., Ung, P. M. U., Raman, R., Gorbatenko, A., Kozono, S., Zhou, X. Z., Brechin, V., Barbaro, J. M., Thompson, R., White, R. M., Aguirre-Ghiso, J. A., Heymach, J. V., Lu, K. P., Silva, J. M., Panageas, K. S., Schlessinger, A., Maki, R. G., & 3 others, 1 Feb 2019, In: Nature Cell Biology. 21, 2, p. 203-213 11 p.Research output: Contribution to journal › Article › peer-review
22 Scopus citations -
How cells handle DNA breaks during mitosis: Detection, signaling, repair, and fate choice
Thompson, R., Gatenby, R. & Sidi, S., Sep 2019, In: Cells. 8, 9, 1049.Research output: Contribution to journal › Review article › peer-review
Open Access8 Scopus citations -
Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?
Liu, P. H. & Sidi, S., 13 Nov 2019, In: Frontiers in Oncology. 9, 1174.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations